• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烟酰胺与卡波金联合治疗对人肿瘤异种移植瘤的影响:氧合及肿瘤控制研究

The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.

作者信息

Stüben G, Stuschke M, Knühmann K, Horsman M R, Sack H

机构信息

Department of Radiotherapy, Strahlenklinik im Universitätsklinikum Essen, Germany.

出版信息

Radiother Oncol. 1998 Aug;48(2):143-8. doi: 10.1016/s0167-8140(98)00006-1.

DOI:10.1016/s0167-8140(98)00006-1
PMID:9783885
Abstract

BACKGROUND AND PURPOSE

This was an investigation to study the effect of giving carbogen and nicotinamide (CON) on pO2 and the radiation response of human xenografted tumours.

MATERIALS AND METHODS

The human xenografts were two sarcomas (ENE2 and ES3) and a glioblastoma (HTZ17). Nicotinamide (500 mg/ kg, i.p.) was administered 60 min before PO2 measurements and irradiation, while carbogen was given for 5 min before and during these treatments. Tumour pO2 was measured with an Eppendorf electrode and radiation response was assessed by local tumour control following irradiation with 10 daily fractions.

RESULTS

All three xenografts were found to be poorly oxygenated (about 80% of all pO2 values were < or =2.5 mmHg). CON treatment improved the oxygenation status in all three tumours such that 65, 52 and 71% of the pO2 values were < or =2.5 mmHg in ENE2, ES3 and HTZ17, respectively. However, only in ES3 was this decrease significant. The TCD50 doses for all tumours were around 52-54 Gy. No significant improvement was seen with CON in ENE2 (TCD50 = 48 Gy) and HTZ17 (TCD50 = 56 Gy), but for the ES3 xenograft a significant decrease to 42 Gy was found.

CONCLUSIONS

The three tumours used in this study appeared to show the same level of hypoxia as measured both by pO2 and radiation response. However, only one tumour showed a significant improvement after CON treatment, suggesting that not all hypoxic human tumours might benefit from this type of therapy.

摘要

背景与目的

本研究旨在探讨给予卡波金和烟酰胺(CON)对人异种移植肿瘤的氧分压(pO2)及放射反应的影响。

材料与方法

人异种移植肿瘤包括两种肉瘤(ENE2和ES3)和一种胶质母细胞瘤(HTZ17)。在进行pO2测量及照射前60分钟腹腔注射烟酰胺(500毫克/千克),同时在这些治疗前及治疗期间给予卡波金5分钟。用Eppendorf电极测量肿瘤pO2,并通过每日10次分割照射后的局部肿瘤控制来评估放射反应。

结果

发现所有三种异种移植肿瘤均存在氧合不足(所有pO2值中约80%≤2.5毫米汞柱)。CON治疗改善了所有三种肿瘤的氧合状态,使得ENE2、ES3和HTZ17中分别有65%、52%和71%的pO2值≤2.5毫米汞柱。然而,只有在ES3中这种降低才具有显著性。所有肿瘤的肿瘤控制剂量50(TCD50)约为52 - 54戈瑞。在ENE2(TCD50 = 48戈瑞)和HTZ17(TCD50 = 56戈瑞)中,CON治疗未显示出显著改善,但对于ES3异种移植肿瘤,TCD50显著降至42戈瑞。

结论

本研究中使用的三种肿瘤通过pO2和放射反应测量显示出相同程度的缺氧。然而,只有一种肿瘤在CON治疗后显示出显著改善,这表明并非所有缺氧的人肿瘤都可能从这种治疗中获益。

相似文献

1
The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.烟酰胺与卡波金联合治疗对人肿瘤异种移植瘤的影响:氧合及肿瘤控制研究
Radiother Oncol. 1998 Aug;48(2):143-8. doi: 10.1016/s0167-8140(98)00006-1.
2
Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.烟酰胺和混合气体作为体内缺氧细胞复氧策略的进一步评估:烟酰胺剂量和照射前呼吸时间的重要性
Br J Cancer. 1993 Aug;68(2):269-73. doi: 10.1038/bjc.1993.326.
3
Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.关于如何应对患者对烟酰胺和混合气体不耐受的临床前研究。
Radiother Oncol. 2004 Mar;70(3):301-9. doi: 10.1016/j.radonc.2004.01.017.
4
The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing.烟酰胺治疗和吸入卡波金后KHT肉瘤的辐射反应。
Radiother Oncol. 1994 May;31(2):117-22. doi: 10.1016/0167-8140(94)90391-3.
5
Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.氧气、卡波金或烟酰胺对正常组织的放射增敏作用:分次X线照射方案的治疗增益比较
Radiother Oncol. 1996 Apr;39(1):53-64. doi: 10.1016/0167-8140(95)01678-3.
6
Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.用于喉癌的含卡波金和烟酰胺的加速放疗(ARCON)
Radiother Oncol. 1998 Aug;48(2):115-22. doi: 10.1016/s0167-8140(98)00043-7.
7
Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.通过将烟酰胺与卡波金呼吸相结合来降低肿瘤中的急性和慢性缺氧。
Acta Oncol. 1994;33(4):371-6. doi: 10.3109/02841869409098431.
8
Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.烟酰胺和碳合气对SCCVII肿瘤及正常组织的放射增敏作用:通过微核试验分析
Radiother Oncol. 1993 Aug;28(2):162-7. doi: 10.1016/0167-8140(93)90009-w.
9
Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.烟酰胺与碳合气联合应用于SCCVII肿瘤的分次π介子或X射线照射中的放射增敏作用。
Radiat Med. 1995 Nov-Dec;13(6):291-5.
10
Lack of perfusion enhancement after administration of nicotinamide and carbogen in patients with glioblastoma: a 99mTc-HMPAO SPECT study.胶质母细胞瘤患者给予烟酰胺和卡波金后灌注增强缺失:一项99mTc-HMPAO单光子发射计算机断层扫描研究
Radiother Oncol. 1998 Aug;48(2):135-42. doi: 10.1016/s0167-8140(98)00053-x.

引用本文的文献

1
How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research.如何调节肿瘤乏氧以进行临床前活体成像研究。
Contrast Media Mol Imaging. 2018 Oct 18;2018:4608186. doi: 10.1155/2018/4608186. eCollection 2018.